Research progress on the pharmacological mechanism, in vivo metabolism and structural modification of Erianin

Biomed Pharmacother. 2024 Apr:173:116295. doi: 10.1016/j.biopha.2024.116295. Epub 2024 Feb 23.

Abstract

Erianin is an important bibenzyl compound in dendrobium and has a wide spectrum of pharmacological properties. Since Erianin was discovered, abundant results have been achieved in the in vitro synthesis, structural modification, and pharmacological mechanism research. Researchers have developed a series of simple and efficient in vitro synthesis methods to improve the shortcomings of poor water solubility by replacing the chemical structure or coating it in nanomaterials. Erianin has a broad anti-tumor spectrum and significant anti-tumor effects. In addition, Erianin also has pharmacological actions like immune regulation, anti-inflammatory, and anti-angiogenesis. A comprehensive understanding of the synthesis, metabolism, structural modification, and pharmacological action pathways of Erianin is of great value for the utilization of Erianin. Therefore, this review conducts a relatively systematic look back at Erianin from the above four aspects, to give a reference for the evolvement and further appliance of Erianin.

Keywords: Erianin; Metabolism; Pharmacological effects; Structural modification; Synthesis.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Bibenzyls* / pharmacology
  • Phenol

Substances

  • Erianin
  • Bibenzyls
  • Phenol
  • Anti-Inflammatory Agents